Aveo Capital Partners’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,115
| Closed | -$13K | – | 179 |
|
|
2020
Q3 | $13K | Hold |
1,115
| – | – | ﹤0.01% | 191 |
|
|
2020
Q2 | $19K | Hold |
1,115
| – | – | 0.04% | 57 |
|
|
2020
Q1 | $7K | Hold |
1,115
| – | – | ﹤0.01% | 156 |
|
|
2019
Q4 | $8K | Hold |
1,115
| – | – | ﹤0.01% | 184 |
|
|
2019
Q3 | $13K | Hold |
1,115
| – | – | 0.01% | 180 |
|
|
2019
Q2 | $35K | Hold |
1,115
| – | – | 0.02% | 182 |
|
|
2019
Q1 | $47K | Hold |
1,115
| – | – | 0.02% | 165 |
|
|
2018
Q4 | $51K | Hold |
1,115
| – | – | 0.03% | 128 |
|
|
2018
Q3 | $77K | Hold |
1,115
| – | – | 0.03% | 137 |
|
|
2018
Q2 | $107K | Hold |
1,115
| – | – | 0.05% | 137 |
|
|
2018
Q1 | $117K | Sell |
1,115
-667
| -37% | -$70K | 0.05% | 138 |
|
|
2017
Q4 | $279K | Buy |
+1,782
| New | +$279K | 0.09% | 105 |
|